Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 3,
  • 1,
  • 1,
  • 4,
  • 4,
  • 1,
  • 1 and
  • 1, 2, 3Email author
Journal of Translational Medicine201412:126

https://doi.org/10.1186/1479-5876-12-126

  • Received: 6 May 2014
  • Accepted: 6 May 2014
  • Published:

The original article was published in Journal of Translational Medicine 2014 12:13

Correction

After publishing this article [1], we noted mistake in the spelling of co-author Rajesh Mukthavaram’s names. The corrected co author name has been included to the author list.

Notes

Authors’ Affiliations

(1)
Translational Neuro-Oncology Laboratories, Moores Cancer Center, UC San Diego, La Jolla, CA 92093, USA
(2)
Department of Neurosciences, UC San Diego, La Jolla, CA 92093, USA
(3)
Moores Cancer Center, UC san Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA
(4)
CellWorks Inc, Irvine, CA, USA

References

  1. Jiang P, Mukthavavam R, Chao Y, Bharati IS, Fogal V, Pastorino S, Cong X, Nomura N, Gallagher M, Abbasi T, Vali S, Pingle SC, Makale M, Kesari S: Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. J Transl Med. 2014, 12: 13-10.1186/1479-5876-12-13.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Jiang et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement